Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative
disorders characterized by different clinical courses, varying from indolent to highly …

Primary mediastinal large B-cell lymphoma (PMLBCL) is a distinct clinical and biological
disease from other types of DLBCL. It is more frequent in young female and constitutes 6 …

Background Primary mediastinal B-cell lymphoma is a distinct subtype of diffuse large-B-cell
lymphoma that is closely related to nodular sclerosing Hodgkin's lymphoma. Patients are …

Cure rates for primary mediastinal large B-cell lymphoma (PMBCL) have improved with the
integration of rituximab. However, the type of primary therapy and role of radiotherapy (RT) …

Primary mediastinal (thymic) large B‐cell lymphoma (PMBCL) is an uncommon subtype of
non‐Hodgkin lymphoma (NHL) that presents with a mediastinal mass and has unique …

We recently reported a truncating deletion in the NFKBIE gene, which encodes IκBε, a
negative feedback regulator of NF-κB, in clinically aggressive chronic lymphocytic leukemia …

Abstract The World Health Organization now recognizes primary mediastinal B-cell
lymphoma (PMBCL) as a unique clinical and biologic entity. PMBCL is distinct from other B …

Diffuse large B-cell lymphomas (DLBCL) are now considered a heterogeneous group of
distinct molecular subtypes (germinal center B-cell DLBCL, activated B-cell DLBCL, and …

Dose-adjusted-EPOCH-R obviates the need for radiotherapy in most patients with primary
mediastinal B-cell lymphoma. End-of-treatment PET, however, does not accurately identify …

Simple Summary Diffuse large B-cell lymphoma (DLBCL) is the most common high-grade
non-Hodgkin lymphoma. The current treatment combining the anti-CD20 monoclonal …